Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV002829541 | SCV003217567 | pathogenic | Mowat-Wilson syndrome | 2022-06-27 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Leu860Serfs*15) in the ZEB2 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in ZEB2 are known to be pathogenic (PMID: 16053902). This variant is not present in population databases (gnomAD no frequency). This variant has not been reported in the literature in individuals affected with ZEB2-related conditions. For these reasons, this variant has been classified as Pathogenic. |